Pharmacological inhibition (e.g., by RSL3 or ML162 treatment) or the genetic ablation of GPX4 induces ferroptosis in a multitude of cancer cell lines (Jiang et al., 2021; Yang et al., 2014). This evidence concerns the gene GPX4 and cancer.